These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4562750)

  • 21. The calculation of probabilities in rejecting bioequivalence.
    Yee KF
    Biometrics; 1986 Dec; 42(4):961-5. PubMed ID: 3814736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rank-based tests for non-inferiority and equivalence hypotheses in multi-centre clinical trials using mixed models.
    Rashid MM
    Stat Med; 2003 Jan; 22(2):291-311. PubMed ID: 12520563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of sample size methods for the logrank statistic.
    Lakatos E; Lan KK
    Stat Med; 1992 Jan; 11(2):179-91. PubMed ID: 1579757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A FORTRAN program for the design and analysis of sequential clinical trials.
    Whitehead J; Marek P
    Comput Biomed Res; 1985 Apr; 18(2):176-83. PubMed ID: 3838715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of some strategies for treating concomitant factors in randomized trials.
    Commenges D
    Methods Inf Med; 1986 Oct; 25(4):237-41. PubMed ID: 3773782
    [No Abstract]   [Full Text] [Related]  

  • 27. Bias and loss: the two sides of a biased coin.
    Atkinson AC
    Stat Med; 2012 Dec; 31(28):3494-503. PubMed ID: 22736426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trials: design and analysis.
    Green SB
    Semin Oncol; 1981 Dec; 8(4):417-23. PubMed ID: 7323813
    [No Abstract]   [Full Text] [Related]  

  • 29. Methods for flexible sample-size design in clinical trials: Likelihood, weighted, dual test, and promising zone approaches.
    Shih WJ; Li G; Wang Y
    Contemp Clin Trials; 2016 Mar; 47():40-8. PubMed ID: 26674739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal design of clinical trials comparing several treatments with a control.
    Marschner IC
    Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical methodology for clinical trials of caries prophylactic agents--current knowledge.
    Worthington H
    Int Dent J; 1984 Dec; 34(4):278-84. PubMed ID: 6597135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression toward the mean in a two-stage selection program. II. Correlated within-subject observations.
    McMahan CA
    Am J Epidemiol; 1987 May; 125(5):912-6. PubMed ID: 3551589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential urn designs with elimination for comparing K > or =3 treatments.
    Coad DS; Ivanova A
    Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-stage plans for the testing of binomial parameters.
    De With C
    Control Clin Trials; 1983 Sep; 4(3):215-26. PubMed ID: 6641235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On some bivariate distributions of number of births.
    Bhattacharya BN; Nath DC
    Sankhya Ser B; 1985 Dec; 47(3):372-84. PubMed ID: 12268172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of data from multiclinic experiments.
    Chakravorti SR; Grizzle JE
    Biometrics; 1975 Jun; 31(2):325-38. PubMed ID: 1100133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paired versus two-sample design for a clinical trial of treatments with dichotomous outcome: power considerations.
    Wacholder S; Weinberg CR
    Biometrics; 1982 Sep; 38(3):801-12. PubMed ID: 7171700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study.
    Schoenfeld DA; Gelber RD
    Biometrics; 1979 Dec; 35(4):825-9. PubMed ID: 526527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relative efficiency of Zelen's prerandomization design for clinical trials.
    Anbar D
    Biometrics; 1983 Sep; 39(3):711-8. PubMed ID: 6652204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the designs of thorough QT/QTc clinical trials.
    Tsong Y
    J Biopharm Stat; 2013; 23(1):43-56. PubMed ID: 23331220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.